Jitao David Zhang

Assistent Lecturer

University of Basel

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Biotechnology Biotechnology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jitao David Zhang is an Assistant Lecturer at the University of Basel, Switzerland. His research focuses on chemical proteomics, drug discovery, and immunology, as evidenced by recent articles on kinase inhibitors, microglial phagocytosis, and pharmacokinetic properties of small molecules. He also explores the implications of Swiss apprenticeships for youth and the development of tools for RNA-seq analysis.

Articles (21)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Amanda Sierra

Research Professor and Group Leader

SPAIN

View details

Mala Maini

Professor of Viral Immunology

UCL

UNITED KINGDOM

View details

Jorge Valero

Associate Professor

Universidad de Salamanca

SPAIN

View details

Marcel Leist

University of Konstanz

GERMANY

View details

Lucie Yammine

Weill Cornell Medical College

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jitao David Zhang

Research Interests

Explore related searches

Contact this professor

About

Articles (21)

CellEKT: A Robust Chemical Proteomics Workflow to Profile Cellular Target Engagement of Kinase Inhibitors

A bottom‐up approach identifies the antipsychotic and antineoplastic trifluoperazine and the ribose derivative deoxytubercidin as novel microglial phagocytosis inhibitors

G–PLIP: Knowledge graph neural network for structure-free protein–ligand bioactivity prediction

A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection

Another string to your bow: machine learning prediction of the pharmacokinetic properties of small molecules

How young people benefit from Swiss apprenticeships.

splicekit: an integrative toolkit for splicing analysis from short-read RNA-seq

A randomized, double-blind phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the NLRP3 inhibitor selnoflast in patients with moderate to severe active ulcerative colitis.

Causal inference in drug discovery and development.

Optimization of the TeraTox Assay for Preclinical Teratogenicity Assessment

Discovery of a first-in-class orally available HBV cccDNA inhibitor.

Discovery of Novel cccDNA Reducers toward the Cure of Hepatitis B Virus Infection.

Cross-reactive immunity potentially drives global oscillation and opposed alternation patterns of seasonal influenza A viruses.

Tissue heterogeneity is prevalent in gene expression studies

Ten simple rules for doing a postdoc in pharma

Focus on germ-layer markers: A human stem cell-based model for in vitro teratogenicity testing

Inducers of the endothelial cell barrier identified through chemogenomic screening in genome-edited hPSC-endothelial cells

Large-Scale Production of Human iPSC-Derived Macrophages for Drug Screening

Signaling pathways predisposing to chronic kidney disease progression

An Introduction to Machine Learning

Multiscale modelling of drug mechanism and safety

Collaborators (5)

Amanda Sierra

Mala Maini

Jorge Valero

Marcel Leist

Lucie Yammine

Make your next move.